Diversified Healthcare Trust(DHC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -1.11 | Insider Own | 10.19% | Shs Outstand | 242.2M | Perf Week | -2.22% |
| Market Cap | 1.82B | Forward P/E | - | EPS next Y | 37.04% | Insider Trans | - | Shs Float | 217.5M | Perf Month | -9.96% |
| Enterprise Value | 4.10B | PEG | - | EPS next Q | -0.15 | Inst Own | 85.37% | Short Float | 5.94% | Perf Quarter | -14.77% |
| Income | -0.27B | P/S | 1.21 | EPS this Y | 47.06% | Inst Trans | 3.16% | Short Ratio | 7.75 | Perf Half Y | 1.08% |
| Sales | 1.50B | P/B | 1.15 | EPS next 5Y | 29.33% | ROA | -5.91% | Short Interest | 12.92M | Perf YTD | 54.64% |
| Book/sh | 6.54 | P/C | 13.33 | EPS past 3/5Y | -161.94% -15.19% | ROE | -15.47% | 52W High | -22.36% ($9.66) | Perf Year | 65.56% |
| Cash/sh | 0.56 | P/FCF | - | Sales past 3/5Y | 6.21% -1.18% | ROIC | -6.65% | 52W Low | 91.33% ($3.92) | Perf 3Y | 231.86% |
| Dividend Est. | $0.04 (0.53%) | EV/EBITDA | 18.59 | EPS Y/Y TTM | 7.49% | Gross Margin | 2.89% | Volatility(W/M) | 2.99% 3.12% | Perf 5Y | 115.52% |
| Dividend TTM | 0.04 | EV/Sales | 2.73 | Sales Y/Y TTM | -1.49% | Oper. Margin | -2.15% | ATR (14) | 0.27 | Perf 10Y | -64.93% |
| Dividend Ex-Date | 2026/7/20 | Quick Ratio | 6.65 | EPS Q/Q | 59.28% | Profit Margin | -17.73% | RSI (14) | 32.17 | Recom | 1.8 |
| Dividend Gr. 3/5Y | - -25.98% | Current Ratio | 6.65 | Sales Q/Q | -4.53% | SMA20 | -4.24% ($7.83) | Beta | 2.27 | Target Price | $10.15 |
| Payout | - | Debt/Eq | 1.53 | Earnings | 2026/8/3 | SMA50 | -11.88% ($8.51) | Rel Volume | 0.88 | Prev Close | $7.54 |
| Employees | - | LT Debt/Eq | 1.53 | EPS/Sales Surpr. | -9.07% -1.45% | SMA200 | 3.06% ($7.28) | Avg Volume(3M) | 1.67M | Price | $7.5 |
| IPO | 1999/10/7 | Option/Short | Yes/Yes | Trades | 9232 | Volume | 1,463,291 | Change | -0.53% |
Company
DHC is a Real Estate sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
This US healthcare REIT owns and operates medical office buildings and senior housing facilities. It holds a diverse portfolio of healthcare real estate assets, including medical office buildings, life sciences facilities, and senior living/nursing care facilities, generating revenue from both rental income and senior housing operations. It is a healthcare REIT business that benefits from the demand for healthcare real estate driven by an aging population.
Over the past 1 year, roughly in the middle
22% below its 1-year high.
DHC has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +47.1% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +231.9% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.53% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 85.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $2B.
FAQ
What kind of company is DHC?
DHC belongs to the Real Estate sector and operates in the REIT - Healthcare Facilities industry.
What is the market cap of DHC?
The market cap of DHC is approximately $1.8B, ranking 2,178 within its sector.
Does DHC pay dividends?
DHC has a dividend yield of approximately 0.53%, with an annual dividend of $0.04.
What is the 52-week high and low for DHC?
DHC has recorded a 52-week high of $9.66 and a low of $3.92.